Issue: July 2016
June 26, 2016
3 min watch
Save

VIDEO: Speaker presents 1 year results from phase 1/2 trial of bimatoprost implant

Issue: July 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

PRAGUE — At the European Glaucoma Society Congress, Keith Martin, MA, DM, MRCP, FRCOphth, discusses interim 1 year results of the phase 1/2 trial of Allergan's sustained-release bimatoprost implant for the treatment of glaucoma.